Ticker Symbol | Entity Name | As Of Date | Company Name | Followers | Employees on Linkedin | Link | Industry | Date Added | Date Updated | Description | Website | Specialities | Logo | HQ.Street | HQ.City | HQ.State | HQ.Country | HQ.Postal | Headcount change in past 24 months | Company Name | Sector | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
private:encellin | 7973731 | Jun 3rd, 2023 12:00AM | Encellin | 0 | 8.00 | Open | Biotechnology Research | Jun 3rd, 2023 06:29PM | Jun 3rd, 2023 06:29PM | Encellin is focused on advancing next generation therapies, starting with endocrine disorders. We are developing a minimally invasive implant delivering therapeutics where needed. Our technology and patient-driven approach combines functional cell therapies with a novel cell encapsulation technology with to treat chronic diseases. | Open | Open | Mountain View | US | Encellin | |||||||
private:encellin | 7973731 | Jun 2nd, 2023 12:00AM | Encellin | 0 | 8.00 | Open | Biotechnology Research | Jun 2nd, 2023 03:34PM | Jun 2nd, 2023 03:34PM | Encellin is focused on advancing next generation therapies, starting with endocrine disorders. We are developing a minimally invasive implant delivering therapeutics where needed. Our technology and patient-driven approach combines functional cell therapies with a novel cell encapsulation technology with to treat chronic diseases. | Open | Open | Mountain View | US | Encellin | |||||||
private:encellin | 7973731 | Jun 1st, 2023 12:00AM | Encellin | 0 | 8.00 | Open | Biotechnology Research | Jun 1st, 2023 12:14PM | Jun 1st, 2023 12:14PM | Encellin is focused on advancing next generation therapies, starting with endocrine disorders. We are developing a minimally invasive implant delivering therapeutics where needed. Our technology and patient-driven approach combines functional cell therapies with a novel cell encapsulation technology with to treat chronic diseases. | Open | Open | Mountain View | US | Encellin | |||||||
private:encellin | 7973731 | May 31st, 2023 12:00AM | Encellin | 0 | 8.00 | Open | Biotechnology Research | May 31st, 2023 01:21PM | May 31st, 2023 01:21PM | Encellin is focused on advancing next generation therapies, starting with endocrine disorders. We are developing a minimally invasive implant delivering therapeutics where needed. Our technology and patient-driven approach combines functional cell therapies with a novel cell encapsulation technology with to treat chronic diseases. | Open | Open | Mountain View | US | Encellin | |||||||
private:encellin | 7973731 | May 30th, 2023 12:00AM | Encellin | 0 | 8.00 | Open | Biotechnology Research | May 30th, 2023 04:43PM | May 30th, 2023 04:43PM | Encellin is focused on advancing next generation therapies, starting with endocrine disorders. We are developing a minimally invasive implant delivering therapeutics where needed. Our technology and patient-driven approach combines functional cell therapies with a novel cell encapsulation technology with to treat chronic diseases. | Open | Open | Mountain View | US | Encellin | |||||||
private:encellin | 7973731 | May 29th, 2023 12:00AM | Encellin | 0 | 8.00 | Open | Biotechnology Research | May 29th, 2023 01:19PM | May 29th, 2023 01:19PM | Encellin is focused on advancing next generation therapies, starting with endocrine disorders. We are developing a minimally invasive implant delivering therapeutics where needed. Our technology and patient-driven approach combines functional cell therapies with a novel cell encapsulation technology with to treat chronic diseases. | Open | Open | Mountain View | US | Encellin | |||||||
private:encellin | 7973731 | May 25th, 2023 12:00AM | Encellin | 0 | 8.00 | Open | Biotechnology Research | May 25th, 2023 05:18PM | May 25th, 2023 05:18PM | Encellin is focused on advancing next generation therapies, starting with endocrine disorders. We are developing a minimally invasive implant delivering therapeutics where needed. Our technology and patient-driven approach combines functional cell therapies with a novel cell encapsulation technology with to treat chronic diseases. | Open | Open | Mountain View | US | Encellin | |||||||
private:encellin | 7973731 | May 24th, 2023 12:00AM | Encellin | 0 | 8.00 | Open | Biotechnology Research | May 24th, 2023 01:49PM | May 24th, 2023 01:49PM | Encellin is focused on advancing next generation therapies, starting with endocrine disorders. We are developing a minimally invasive implant delivering therapeutics where needed. Our technology and patient-driven approach combines functional cell therapies with a novel cell encapsulation technology with to treat chronic diseases. | Open | Open | Mountain View | US | Encellin | |||||||
private:encellin | 7973731 | May 23rd, 2023 12:00AM | Encellin | 0 | 8.00 | Open | Biotechnology Research | May 23rd, 2023 09:08PM | May 23rd, 2023 09:08PM | Encellin is focused on advancing next generation therapies, starting with endocrine disorders. We are developing a minimally invasive implant delivering therapeutics where needed. Our technology and patient-driven approach combines functional cell therapies with a novel cell encapsulation technology with to treat chronic diseases. | Open | Open | Mountain View | US | Encellin | |||||||
private:encellin | 7973731 | May 22nd, 2023 12:00AM | Encellin | 0 | 8.00 | Open | Biotechnology Research | May 22nd, 2023 03:19PM | May 22nd, 2023 03:19PM | Encellin is focused on advancing next generation therapies, starting with endocrine disorders. We are developing a minimally invasive implant delivering therapeutics where needed. Our technology and patient-driven approach combines functional cell therapies with a novel cell encapsulation technology with to treat chronic diseases. | Open | Open | Mountain View | US | Encellin |